Summary
UnitedHealth Group Inc. (UNH) filed an 8-K on February 28, 2013, to report on the issuance of a significant aggregate principal amount of debt securities. The company successfully sold $2.25 billion in notes across four tranches: $250 million in Floating Rate Notes due August 28, 2014, $500 million in 1.625% Notes due March 15, 2019, $750 million in 2.875% Notes due March 15, 2023, and $750 million in 4.250% Notes due March 15, 2043. This debt issuance was conducted under an existing automatic shelf registration statement and utilized an Underwriting Agreement and Pricing Agreement with a syndicate of prominent financial institutions, including Barclays Capital Inc., Citigroup Global Markets Inc., and others. The filing confirms the execution of these agreements and the issuance of the notes on February 28, 2013, under a pre-existing indenture. This action suggests the company is strategically managing its capital structure, likely to fund ongoing operations, growth initiatives, or refinance existing debt.
Key Highlights
- 1UnitedHealth Group issued a total of $2.25 billion in new debt.
- 2The debt issuance comprises four separate note series with varying maturities and interest rates.
- 3The issuance includes $250 million in Floating Rate Notes due 2014, $500 million in 1.625% Notes due 2019, $750 million in 2.875% Notes due 2023, and $750 million in 4.250% Notes due 2043.
- 4The debt was issued under an existing automatic shelf registration statement on Form S-3.
- 5The company entered into Underwriting and Pricing Agreements with a syndicate of major investment banks.
- 6The issuance occurred on February 28, 2013, reflecting active capital management.
- 7Legal opinions from internal counsel and external law firm Hogan Lovells US LLP were filed, confirming the validity of the notes.